Safety and efficacy of recombinant gamma interferon in the treatment of systemic sclerosis.

OBJECTIVE: To evaluate the safety and efficacy of recombinant gamma interferon (rIFN gamma) in the treatment of patients with systemic sclerosis. METHODS: Sixteen patients with systemic sclerosis were treated with r-IFN gamma, 60 micrograms m-2 (low dose, n = 10) and 150 micrograms m-2 (high dose, n...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Vlachoyiannopoulos, P G, Tsifetaki, N, Dimitriou, I, Galaris, D, Papiris, S A, Moutsopoulos, H M
Format: Artigo
Jezik:Inglês
Izdano: 1996
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC1010296/
https://ncbi.nlm.nih.gov/pubmed/8984943
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki